Correlation Between Neurobo Pharmaceuticals and Kiora Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and Kiora Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and Kiora Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurobo Pharmaceuticals and Kiora Pharmaceuticals, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and Kiora Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of Kiora Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and Kiora Pharmaceuticals.

Diversification Opportunities for Neurobo Pharmaceuticals and Kiora Pharmaceuticals

0.36

Correlation Coefficient

Neurobo Pharmaceuticals  Kiora Pharmaceuticals

Weak diversification

The 3 months correlation between Neurobo and Kiora is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and Kiora Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiora Pharmaceuticals and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with Kiora Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiora Pharmaceuticals has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and Kiora Pharmaceuticals go up and down completely randomly.

Pair Corralation between Neurobo Pharmaceuticals and Kiora Pharmaceuticals

Given the investment horizon of 90 days Neurobo Pharmaceuticals is expected to under-perform the Kiora Pharmaceuticals. In addition to that, Neurobo Pharmaceuticals is 1.33 times more volatile than Kiora Pharmaceuticals. It trades about -0.11 of its total potential returns per unit of risk. Kiora Pharmaceuticals is currently generating about 0.02 per unit of volatility. If you would invest  354.00  in Kiora Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of  3.00  from holding Kiora Pharmaceuticals or generate 0.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Neurobo Pharmaceuticals  vs.  Kiora Pharmaceuticals

Neurobo Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neurobo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Kiora Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Kiora Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Kiora Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Neurobo Pharmaceuticals and Kiora Pharmaceuticals

The main advantage of trading using opposite Neurobo Pharmaceuticals and Kiora Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, Kiora Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiora Pharmaceuticals will offset losses from the drop in Kiora Pharmaceuticals' long position.

The idea behind Neurobo Pharmaceuticals and Kiora Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.